These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 37658639)

  • 1. Tone management: An environmental scan of current management practices across Canada.
    Tran MA; Thipse M; Tsampalieros A; Webster R; McCormick A; Alazem H; Venkateswaran S; Cheung K; Smit K; Tu A
    Child Care Health Dev; 2024 Jan; 50(1):e13169. PubMed ID: 37658639
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intrathecal baclofen pumps in the management of hypertonia in childhood: a UK and Ireland wide survey.
    Lodh R; Amin S; Ammar A; Bellis L; Brink P; Calisto A; Crimmins D; Eunson P; Forsyth RJ; Goodden J; Kaminska M; Kehoe J; Kirkpatrick M; Kumar R; Leonard J; Lording A; Martin K; Miller R; Mordekar SR; Pettorini B; Smith M; Smith R; Sneade C; Whitney A; Vloeberghs M; Zaki H; Lumsden DE
    Arch Dis Child; 2021 Dec; 106(12):1202-1206. PubMed ID: 33853760
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Continuously infused intrathecal baclofen over 12 months for spastic hypertonia in adolescents and adults with cerebral palsy.
    Meythaler JM; Guin-Renfroe S; Law C; Grabb P; Hadley MN
    Arch Phys Med Rehabil; 2001 Feb; 82(2):155-61. PubMed ID: 11239304
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacological management of abnormal tone and movement in cerebral palsy.
    Lumsden DE; Crowe B; Basu A; Amin S; Devlin A; DeAlwis Y; Kumar R; Lodh R; Lundy CT; Mordekar SR; Smith M; Cadwgan J
    Arch Dis Child; 2019 Aug; 104(8):775-780. PubMed ID: 30948360
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Management of hypertonia in cerebral palsy.
    Nahm NJ; Graham HK; Gormley ME; Georgiadis AG
    Curr Opin Pediatr; 2018 Feb; 30(1):57-64. PubMed ID: 29135566
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interventions for eye movement disorders due to acquired brain injury.
    Rowe FJ; Hanna K; Evans JR; Noonan CP; Garcia-Finana M; Dodridge CS; Howard C; Jarvis KA; MacDiarmid SL; Maan T; North L; Rodgers H
    Cochrane Database Syst Rev; 2018 Mar; 3(3):CD011290. PubMed ID: 29505103
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Improvements in children with cerebral palsy following intrathecal baclofen: use of the Rehabilitation Institute of Chicago Care and Comfort Caregiver Questionnaire (RIC CareQ).
    Baker KW; Tann B; Mutlu A; Gaebler-Spira D
    J Child Neurol; 2014 Mar; 29(3):312-7. PubMed ID: 23420651
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Orally delivered baclofen to control spastic hypertonia in acquired brain injury.
    Meythaler JM; Clayton W; Davis LK; Guin-Renfroe S; Brunner RC
    J Head Trauma Rehabil; 2004; 19(2):101-8. PubMed ID: 15247821
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intrathecal baclofen for treating spasticity in children with cerebral palsy.
    Hasnat MJ; Rice JE
    Cochrane Database Syst Rev; 2015 Nov; 2015(11):CD004552. PubMed ID: 26563961
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Safety and efficacy of intrathecal baclofen trials for the treatment of hypertonia: a retrospective cohort study.
    Abdelmageed S; Horak VJ; Mossner J; Wang R; Krater T; Raskin JS
    J Neurosurg Pediatr; 2024 Feb; 33(2):179-184. PubMed ID: 38064708
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Botulinum toxin-A use in paediatric hypertonia: Canadian practice patterns.
    Fehlings D; Narayanan U; Andersen J; Beauchamp R; Gorter JW; Kawamura A; Kiefer G; Mason M; McCormick A; Mesterman R; Switzer L; Watt J
    Can J Neurol Sci; 2012 Jul; 39(4):508-15. PubMed ID: 22728860
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacological and neurosurgical interventions for managing dystonia in cerebral palsy: a systematic review.
    Fehlings D; Brown L; Harvey A; Himmelmann K; Lin JP; Macintosh A; Mink JW; Monbaliu E; Rice J; Silver J; Switzer L; Walters I
    Dev Med Child Neurol; 2018 Apr; 60(4):356-366. PubMed ID: 29405267
    [TBL] [Abstract][Full Text] [Related]  

  • 13. National surveillance of oral medication prescription for children with dystonic cerebral palsy.
    Harvey A; Bear N; Rice J; Antolovich G; Waugh MC
    J Paediatr Child Health; 2021 Aug; 57(8):1222-1227. PubMed ID: 33655652
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oral medication prescription practices of tertiary-based specialists for dystonia in children with cerebral palsy.
    Harvey A; Reddihough D; Scheinberg A; Williams K
    J Paediatr Child Health; 2018 Apr; 54(4):401-404. PubMed ID: 29105865
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effectiveness of botulinum toxin A for upper and lower limb spasticity in children with cerebral palsy: a summary of evidence.
    Lukban MB; Rosales RL; Dressler D
    J Neural Transm (Vienna); 2009 Mar; 116(3):319-31. PubMed ID: 19142573
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Botulinum toxin A in management of cerebral palsy.
    Calderon-Gonzalez R; Calderon-Sepulveda R; Rincon-Reyes M; Garcia-Ramirez J; Mino-Arango E
    Pediatr Neurol; 1994 Jun; 10(4):284-8. PubMed ID: 8068154
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intrathecal baclofen therapy in children: an analysis of individualized goals.
    Liew PY; Stewart K; Khan D; Arnup SJ; Scheinberg A
    Dev Med Child Neurol; 2018 Apr; 60(4):367-373. PubMed ID: 29349778
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Medical Updates in Management of Hypertonia.
    Dy R; Roge D
    Phys Med Rehabil Clin N Am; 2020 Feb; 31(1):57-68. PubMed ID: 31760994
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hypertonia.
    Evans SH; Cameron MW; Burton JM
    Curr Probl Pediatr Adolesc Health Care; 2017 Jul; 47(7):161-166. PubMed ID: 28716516
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of botulinum toxin type A on cerebral palsy with upper limb spasticity.
    Yang TF; Fu CP; Kao NT; Chan RC; Chen SJ
    Am J Phys Med Rehabil; 2003 Apr; 82(4):284-9. PubMed ID: 12649654
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.